Then, we used the CaSR inhibitor NPS2134, the fast Ca2+ chelator BAPTA-AM and Akt inhibitor MK2206 to block spermine-induced β-catenin nuclear accumulation and examined STT3A expression in HCC cells. The gene discussed is STT3A; the disease is hepatocellular carcinoma.